Codrin Lungu

8.3k total citations · 1 hit paper
56 papers, 1.9k citations indexed

About

Codrin Lungu is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Codrin Lungu has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Neurology, 25 papers in Cellular and Molecular Neuroscience and 8 papers in Psychiatry and Mental health. Recurrent topics in Codrin Lungu's work include Neurological disorders and treatments (33 papers), Botulinum Toxin and Related Neurological Disorders (20 papers) and Parkinson's Disease Mechanisms and Treatments (15 papers). Codrin Lungu is often cited by papers focused on Neurological disorders and treatments (33 papers), Botulinum Toxin and Related Neurological Disorders (20 papers) and Parkinson's Disease Mechanisms and Treatments (15 papers). Codrin Lungu collaborates with scholars based in United States, Austria and Japan. Codrin Lungu's co-authors include Mark Hallett, Ami Mankodi, Charles A. Thornton, Maurice S. Swanson, Douglas W Esson, Rahul Kanadia, Karen A. Johnstone, William W. Hauswirth, Adrian M. Timmers and Kareem A. Zaghloul and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Codrin Lungu

56 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Muscleblind Knockout Model for Myotonic Dystrophy

2003 576 citations Rahul Kanadia, Karen A. Johnstone et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Codrin Lungu United States	22	912	872	655	300	221	56	1.9k
Sharon Hassin‐Baer Israel	33	1.8k 2.0×	729 0.8×	540 0.8×	362 1.2×	215 1.0×	127	2.8k
Peter A. Pahapill United States	19	800 0.9×	811 0.9×	427 0.7×	234 0.8×	98 0.4×	39	1.7k
Herbert Schreiber Germany	21	418 0.5×	314 0.4×	332 0.5×	409 1.4×	200 0.9×	62	1.4k
Hans‐Wilhelm Müller Germany	22	278 0.3×	462 0.5×	332 0.5×	398 1.3×	207 0.9×	69	2.0k
Paul J. Mattis United States	24	1.8k 1.9×	862 1.0×	609 0.9×	870 2.9×	402 1.8×	40	3.2k
Martina Minnerop Germany	25	768 0.8×	916 1.1×	661 1.0×	217 0.7×	138 0.6×	62	1.6k
Kit Wu United Kingdom	19	1.4k 1.6×	970 1.1×	445 0.7×	293 1.0×	156 0.7×	34	2.3k
Marcella Masciullo Italy	25	317 0.3×	572 0.7×	512 0.8×	234 0.8×	115 0.5×	57	1.4k
Bülent Elibol Türkiye	20	1.0k 1.1×	755 0.9×	501 0.8×	169 0.6×	112 0.5×	58	1.8k
Andrea Ciammola Italy	23	1.1k 1.2×	2.0k 2.3×	1.7k 2.5×	188 0.6×	124 0.6×	64	2.9k

Countries citing papers authored by Codrin Lungu

Since Specialization

Citations

This map shows the geographic impact of Codrin Lungu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Codrin Lungu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Codrin Lungu more than expected).

Fields of papers citing papers by Codrin Lungu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Codrin Lungu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Codrin Lungu. The network helps show where Codrin Lungu may publish in the future.

Co-authorship network of co-authors of Codrin Lungu

This figure shows the co-authorship network connecting the top 25 collaborators of Codrin Lungu. A scholar is included among the top collaborators of Codrin Lungu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Codrin Lungu. Codrin Lungu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lungu, Codrin, et al.. (2024). Update in exploring the connection and clinical implications between vitamin D and knee osteoarthritis. SHILAP Revista de lepidopterología. 15(Vol.15, no. 3). 736–736. 3 indexed citations

Heiss, John D., Abhik Ray‐Chaudhury, David E. Kleiner, et al.. (2024). Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2‐GDNF in a Patient with Parkinson's Disease. Movement Disorders. 39(8). 1412–1417. 10 indexed citations

McGurrin, Patrick, Gina Norato, Codrin Lungu, et al.. (2023). Objective response to ethanol in essential tremor: results from a standardized ethanol challenge study. Annals of Clinical and Translational Neurology. 11(1). 156–168. 7 indexed citations

Luca, Daniel G. Di, Eric A. Macklin, Lindsay Pothier, et al.. (2023). Enrollment of Participants From Marginalized Racial and Ethnic Groups. Neurology Clinical Practice. 13(1). e200113–e200113. 7 indexed citations

Wong, Ka‐Ho, Gregory S. Day, Maarten J. Titulaer, et al.. (2022). The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. Neurology. 99(23_Supplement_2). 1 indexed citations

Ehrlich, Debra, Codrin Lungu, Russell R. Lonser, et al.. (2022). Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease. Molecular Therapy. 30(12). 3632–3638. 31 indexed citations

Hattori, Takaaki, Richard C. Reynolds, Edythe Wiggs, et al.. (2022). Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson’s disease. NeuroImage Clinical. 35. 103100–103100. 12 indexed citations

Stephen, Christopher D., Codrin Lungu, & Alberto J. Espay. (2020). Healthcare utilization and inpatient/emergency department costs in adult and pediatric functional neurological disorders: a growing problem (1902). Neurology. 94(15_supplement). 1 indexed citations

Taylor, Paul A., et al.. (2020). Executive function network’s white matter alterations relate to Parkinson’s disease motor phenotype. Neuroscience Letters. 741. 135486–135486. 6 indexed citations

10.

Park, Jung E., Ejaz A. Shamim, Pattamon Panyakaew, et al.. (2019). Botulinum toxin and occupational therapy for Writer's cramp. Toxicon. 169. 12–17. 4 indexed citations

11.

Simuni, Tanya, Robert G. Holloway, David Oakes, Kevin Biglan, & Codrin Lungu. (2018). A Phase 3 study of Isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Baseline characteristics and study update (P2.039). Neurology. 90(15_supplement). 5 indexed citations

12.

Richardson, Sarah Pirio, Eckart Altenmüller, Katharine E. Alter, et al.. (2017). Research Priorities in Limb and Task-Specific Dystonias. Frontiers in Neurology. 8. 170–170. 31 indexed citations

13.

Lungu, Codrin, et al.. (2015). iPad App for Daily Parkinson Diary (P1.193). Neurology. 84(14_supplement). 1 indexed citations

14.

Vanegas, Nora, et al.. (2014). Beta-Coupled High-Frequency Activity and Beta-Locked Neuronal Spiking in the Subthalamic Nucleus of Parkinson's Disease. Journal of Neuroscience. 34(38). 12816–12827. 91 indexed citations

15.

Voller, Bernhard, et al.. (2013). Alcohol challenge and the sensitivity to change of the essential tremor rating assessment scale (TETRAS). Journal of the Neurological Sciences. 333. e77–e77. 1 indexed citations

16.

Tarsy, Daniel, Codrin Lungu, & Ross J. Baldessarini. (2011). Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs. Handbook of clinical neurology. 100. 601–616. 67 indexed citations

17.

Vanbellingen, Tim, Codrin Lungu, Fabio Baronti, et al.. (2011). Short and valid assessment of apraxia in Parkinson’s disease. Parkinsonism & Related Disorders. 18(4). 348–350. 16 indexed citations

18.

Lungu, Codrin, Andrew Tarulli, Daniel Tarsy, et al.. (2010). Quantifying muscle asymmetries in cervical dystonia with electrical impedance: A preliminary assessment. Clinical Neurophysiology. 122(5). 1027–1031. 13 indexed citations

19.

Lungu, Codrin, et al.. (2009). The Use of Diagnostic Tests in Patients with Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 18(3). 178–184. 27 indexed citations

20.

Kanadia, Rahul, Karen A. Johnstone, Ami Mankodi, et al.. (2003). A Muscleblind Knockout Model for Myotonic Dystrophy. Science. 302(5652). 1978–1980. 576 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact